Nobel Prize in Chemistry 2026: candidates and fields in play

The Nobel Prize in Chemistry 2026 will be announced on 7 October. The award almost always goes to a field rather than to a single paper, and this year three fields draw most of the attention: self-assembled monolayers, precision gene editing, and long-range electron transfer in proteins. Six groups of candidates account for most of the remaining speculation, and each rests on a different kind of claim.

Why the chemistry prize is hard to guess and easy to narrow

The chemistry prize has been handed out 117 times since 1901, to 200 laureates, and the list looks random until you sort it by theme. What the Royal Swedish Academy of Sciences tends to reward is a technique or a concept that other scientists can pick up and build a field on top of, which is rarely the decade’s most cited paper.

A citation-based watchlist works better than a poll for that reason. One such list, running for more than two decades, has named close to 500 researchers, and around 89 of them have gone on to win, roughly one in six. Those odds are respectable, and they are not a forecast.

The list also fails in a predictable way. In 2024, three researchers who had worked on protein structure prediction appeared on it in September and won the chemistry prize in October, which is about as sharp as a prediction gets. In 2025 the academy went to three chemists who built metal-organic frameworks, a family of porous crystals with enormous internal surface area, and the commentary ahead of time had almost nothing to say about them.

A preview like this one is a map of where the field’s center of gravity currently sits, which is not the same thing as a list of winners.

Self-assembled monolayers: chemistry one molecule thick

A self-assembled monolayer does what the name says. Molecules with a reactive head group chemisorb onto a solid surface and then pack into an ordered film one molecule thick. The head group anchors, the tail points outward, and the packing happens without help, because the molecules settle into a lower-energy arrangement together than they would apart.

The foundational work came in the 1980s. David Allara, then working on surface spectroscopy, and Ralph Nuzzo, working on metal surfaces, showed that alkanethiols form well-ordered films on gold. Jacob Sagiv came at the same problem from the silane side, building monolayers on oxide surfaces.

These films are still the thinnest useful interface engineering tool chemists have. They set wettability, block corrosion, template crystal growth, and carry charge between a transparent electrode and a light-absorbing film. Every biosensor surface built to resist nonspecific protein binding, and every catalyst built to expose a single crystal face, sits downstream of that 1980s work. In perovskite photovoltaics, a self-assembled monolayer now sits directly between the electrode and the absorber, and how uniform that layer is decides how efficient the cell turns out to be.

Precision gene editing: rewriting DNA without cutting it

Base editing arrived in 2016. It uses a catalytically impaired CRISPR-associated protein to carry a chemical modification enzyme to a precise genomic address, then converts one DNA base pair into another without cutting both strands. Prime editing arrived in 2019 and widened what the approach can do: it substitutes bases and also inserts or deletes short stretches of sequence.

Both techniques came out of David Liu’s laboratory at Harvard and the Broad Institute, where he directs the Merkin Institute for Transformative Technologies in Healthcare and holds a Howard Hughes Medical Institute appointment. He graduated from Harvard in 1994, took a doctorate at the University of California, Berkeley in 1999, and returned to Harvard to teach that same year.

The clinical relevance stopped being hypothetical some time ago. Several therapies built on base editing and prime editing are in trials across multiple countries, aimed at inherited disease, and Liu received a Breakthrough Prize in 2025 for the work.

The sequence matters here. CRISPR itself, the platform Charpentier and Doudna developed and shared the 2020 Nobel Prize in Chemistry for, cuts DNA and hands the repair back to the cell, so the result depends partly on the cell. Base and prime editing keep the targeting machinery and drop the cutting. The edit gets written, and nothing has to be repaired.

Protein electron transfer over long distances: charge through a crowded medium

Electrons move through proteins across distances that would be impossible in a vacuum at biological timescales. Two chemists at the California Institute of Technology, Harry Gray and Jay Winkler, have spent decades working out how. Their experiments attach a photoexcitable metal complex to one site of a protein and a quencher to another, then measure how fast the electron arrives. The answer depends on distance, on the structure of the medium in between, and on whether aromatic side chains offer a route.

Nearly every energy-converting system in biology runs on controlled, directional electron transfer, from the respiratory complexes to the photosynthetic reaction centers, and so does every enzyme that depends on a metal cofactor. Working out the rules changed how researchers approach targeted drug therapy, because a drug that has to move an electron has to be designed around the protein’s own transfer pathways. The same rules govern artificial systems built for clean energy production.

The six candidate groups most often named for the 2026 Nobel Prize in Chemistry

Outside those three research directions, the discussion usually settles on six groups, and each rests on a different kind of claim. Some are honored for a foundational discovery that took decades to pay off. Others are honored for technology that has already reached patients.

Candidate group	Research area	Why this group is in the conversation
Hartl, Horwich, Mori, Walter	Protein folding and chaperones	Shared a major international frontiers-of-knowledge prize; the work underpins protein research generally
Matyjaszewski, Sawamoto	Atom transfer radical polymerization	Franklin Medal recipients; turned a reaction once called impossible into a routine tool
Bassler, Greenberg, Gordon	Quorum sensing and the gut microbiome	A 2026 Copley Medal and a 2026 Gabbay Award between them
Wong, Collins	Oligosaccharide synthesis and synthetic biology	Technologies licensed by more than 25 companies and already in clinical use
Balasubramanian, Klenerman	Next-generation DNA sequencing	Cut the time and cost of a human genome by roughly a millionfold
Brangwynne, Hyman, Rosen	Biomolecular condensates	Reframed how cells organize biochemistry; the discovery is recent

Protein folding and chaperones: Hartl, Horwich, Mori and Walter

Four names appear in two pairings. Ulrich Hartl and Arthur Horwich worked out how a cell folds a newly made protein without letting it aggregate into a useless clump, and identified the molecular chaperones that carry out the folding. Kazutoshi Mori and Peter Walter worked out how the cell detects misfolded protein inside the endoplasmic reticulum and signals for help, a pathway now understood as central to a long list of diseases.

The four shared a major international frontiers-of-knowledge award three years ago, the kind of recognition that tends to come before the next step. Hartl added a Japanese medical science prize in mid-September 2026.

This work reads as Nobel material because it explains where protein-based disease comes from. Folding failure is now a recognized mechanism behind neurodegeneration, and the unfolded protein response is a drug target in its own right. Four names against a three-person limit means the academy would have to choose a subset, which is where the uncertainty sits.

Atom transfer radical polymerization: Matyjaszewski and Sawamoto

In 1995, a postdoctoral researcher working in Krzysztof Matyjaszewski’s laboratory at Carnegie Mellon University found a way to run a radical polymerization with control over chain length and architecture. The reaction, atom transfer radical polymerization, had been considered essentially unattainable, because radical chains normally terminate each other too quickly to be steered. Mitsuo Sawamoto at Kyoto University and his colleague Masami Kamigaito published a metal-catalyzed living radical polymerization in the same period.

The two groups then spent a decade widening the reaction system until it became a general method for making polymers with a defined shape: block copolymers, star polymers, brushes, and surfaces grown outward from a substrate.

That last capability is why the chemistry shows up far outside polymer science. Atom transfer radical polymerization is how a dense polymer brush is grown on a nanoparticle, how a block copolymer is tuned to self-assemble into a target nanoscale pattern, and how a functional surface is made that resists fouling. Both chemists have collected a long list of international awards, including the Franklin Medal.

Quorum sensing and the gut microbiome: Bassler, Greenberg and Gordon

This group is more unusual than the others, because it combines two lines of work that only converged later. Bonnie Bassler and E. Peter Greenberg established that bacteria are not silent single cells. They release small molecules called autoinducers, and the local concentration of those molecules tells each cell how many neighbors it has. When density crosses a threshold, gene expression changes across the population. Bacteria form biofilms, or switch on virulence factors, on the strength of that signal.

Jeffrey Gordon approached microbes from the host side. His work on the gut microbiome established how much of human physiology depends on the bacterial community in the colon, from nutrient extraction and energy balance to immune development.

The two lines now meet in drug discovery. Because virulence in many pathogens is a quorum-sensing output rather than a growth program, blocking the signal offers a way to disarm a bacterium without killing it, which should apply far less selective pressure for resistance than a conventional antibiotic.

Bassler took the Copley Medal in 2026, the oldest scientific award still given. Gordon took the Gabbay Award the same year, a prize with a reputation as a bellwether for biotech-adjacent Nobels. Neither has a Lasker, which is the objection usually raised against this pairing, and the omission carries less weight in chemistry than it does in medicine.

Oligosaccharide synthesis and synthetic biology: Wong and Collins

Chi-Huey Wong turned the chemistry of complex carbohydrates into a practical discipline. He was the first to synthesize complex polysaccharides and glycopeptides at scale using enzymatic methods, and his programmable one-pot synthesis was the first automated route to oligosaccharides and remains among the fastest ways to assemble them. Before that work, oligosaccharide chemistry was a slow, expert-only craft. Afterward, defined sugars became reagents that biologists could order and test.

James J. Collins is one of the founders of synthetic biology. His laboratory now builds next-generation diagnostics and therapeutics on engineered genetic circuits. Technologies from his group have been licensed by more than 25 biotechnology, pharmaceutical, and medical device companies, and he has co-founded several ventures, including Synlogic, Senti Biosciences, Sherlock Biosciences, Cellarity, and Phare Bio. He received the Gabbay Award in 2017.

This pairing is the optimistic one on the list. Wong is sometimes grouped with Peter H. Seeberger instead, and parts of Collins’s work are still working through clinical validation.

Next-generation DNA sequencing: Balasubramanian and Klenerman

Shankar Balasubramanian and David Klenerman invented the chemistry behind next-generation sequencing, which made large-scale genome reading fast, accurate, and cheap. Two numbers make the scale of that change easy to see. In 2000, sequencing one human genome took more than a decade and cost over a billion US dollars. Today it takes about a day and costs roughly a thousand dollars, and more than a million human genomes are sequenced each year.

That is a millionfold improvement in one generation of technology, and it is why biology became a data science. Cancer genomics, rare disease diagnosis, population-scale biobanks, and genomic surveillance of pathogens all rest on the assumption that reading a genome is routine. The academy tends to like this shape of contribution: a chemistry problem solved, with a measurable effect on how an entire field operates.

Biomolecular condensates: Brangwynne, Hyman and Rosen

The three researchers behind this entry showed that liquid-liquid phase separation is a general organizing principle inside cells. Cell biology had long assumed that compartments are bounded by membranes. Biomolecular condensates have no membrane. Proteins and RNA with multiple weak interaction sites come together spontaneously into droplets that are dynamic and reversible, so a cell can concentrate a reaction in space and time without building a wall around it.

Each brought a different piece. Clifford Brangwynne used quantitative physics to show that the structures behave like liquids, and mapped how they nucleate and how they respond to force. Anthony Hyman tied condensates to disease, including the way they go wrong in neurodegeneration and viral infection. Michael Rosen worked out the physical chemistry behind multivalent-driven phase separation and rebuilt natural condensates from defined components.

The disease link is what makes this more than a curiosity. Pathological aggregation of proteins such as TDP-43, the protein at the center of most cases of amyotrophic lateral sclerosis, now reads as abnormal phase separation.

The obvious objection to this entry is age. The field is young, the mechanistic debates are still live, and the academy has historically waited longer for a concept to settle.

Where the 2026 prize could go somewhere else

Every year, a large share of the discussion turns out to be wrong, and the mistakes usually concern which field will win. Observers predict the field they can see, and the academy picks the one that has become indispensable.

Three areas outside this shortlist deserve a mention. Photoredox catalysis, and the wider use of light to drive bond formation, has moved from a laboratory curiosity to a standard route in pharmaceutical process chemistry. Metal-organic frameworks, honored in 2025, opened a related question about whether porous materials for gas capture and water harvesting merit a second chemistry prize. The chemistry of targeted protein degradation, where a molecule recruits the cell’s own disposal machinery to remove a chosen protein, is a fast-moving area with real drugs behind it.

How to read a Nobel Prize prediction without being misled

• Treat the list as a set of fields rather than a set of names. The field is right more often than the individual.
• Weigh recognition patterns. A major international prize and a national academy award arriving in the same year is a strong signal.
• Check the age of the concept. The academy waits until a discovery’s importance is settled, so very recent work usually loses.
• Count the collaborators. A group of four or five cannot all win at once, so any prediction has to name which subset.
• Ignore the Lasker objection. Not every chemistry laureate held a Lasker, and the overlap in chemistry is weaker than in medicine.
• Expect at least one surprise. The announced field is often adjacent to the predicted one.

Limitations of any Nobel Prize in Chemistry prediction

Nothing here is a forecast with a probability attached. The deliberations of the Nobel Committee are sealed for fifty years, and no outside observer has access to the nomination list, the shortlist, or the arguments made in the committee room. A watchlist built from citation data measures influence, and influence is not the same thing as the criteria the academy applies. The academy also weighs factors that citation counts cannot capture: whether a field has settled, whether a discovery is read as chemistry rather than biology or physics, and how the three-person limit can be filled without slighting a contributor.

Treat a prediction like this one as a map of where chemistry currently has momentum. Expect the actual decision to rest on grounds that no outside observer can see.

Bottom line

The 2026 chemistry prize will be announced on 7 October. The three research directions that have attracted the most attention are self-assembled monolayers, precision gene editing, and long-range electron transfer in proteins. Alongside those, six groups of candidates appear repeatedly in discussion, spanning protein folding, controlled radical polymerization, quorum sensing and the microbiome, carbohydrate synthesis and synthetic biology, genome sequencing, and biomolecular condensates. Any of them could win, more than one of them will not, and the field that actually wins may be the one nobody put first.

FAQ

When will the Nobel Prize in Chemistry 2026 be announced

The chemistry prize will be announced on Wednesday 7 October 2026. The Royal Swedish Academy of Sciences in Stockholm opens its press conference at 11:45 Central European Summer Time at the earliest. The medicine prize is announced on 5 October and physics on 6 October. All announcements are streamed live on the official Nobel channels.

What is the Nobel Prize in Chemistry awarded for

The prize recognizes a discovery or an improvement in chemistry that has changed how a field operates. The will of Alfred Nobel asks for the person who made the most important chemical discovery or improvement during the preceding year, though in practice the academy rewards work whose importance has had time to become visible to the wider field.

Who is most often named for the 2026 Nobel Prize in Chemistry

The names that appear most often include Ulrich Hartl and Arthur Horwich for protein folding, Krzysztof Matyjaszewski and Mitsuo Sawamoto for atom transfer radical polymerization, Bonnie Bassler and Peter Greenberg for quorum sensing, David Liu for base editing, and Shankar Balasubramanian with David Klenerman for genome sequencing chemistry.

What are biomolecular condensates and why do they matter

Biomolecular condensates are membrane-free droplets that form inside cells when proteins and RNA carrying multiple weak binding sites separate from the surrounding liquid. They concentrate specific molecules in space and time, which lets a cell run a reaction in one place and hold it back in another. Abnormal condensate behavior is now linked to neurodegeneration.

What is base editing and how is it different from CRISPR

Base editing uses a CRISPR-associated protein that can still bind DNA but no longer cuts it, and attaches a chemical enzyme that converts one base pair into another. Standard CRISPR instead cuts both DNA strands and relies on the cell to repair the break, which produces unpredictable insertions and deletions. Base editing skips the break entirely.

What is atom transfer radical polymerization used for

Atom transfer radical polymerization makes polymers with controlled chain length and architecture. It is used to grow dense polymer brushes on nanoparticles and flat surfaces, to build block copolymers that self-assemble into nanoscale patterns, and to create coatings that resist fouling. Drug delivery carriers, thermoplastic elastomers, and separation membranes all depend on it.

What is quorum sensing and why does it matter for drug discovery

Quorum sensing is the mechanism bacteria use to sense how many neighbors they have. Each cell releases small autoinducer molecules, and when the local concentration passes a threshold the population switches on genes as a group, including genes for biofilm formation and virulence. Blocking that signal can disarm a pathogen without killing it.

What is a self-assembled monolayer

A self-assembled monolayer is a film one molecule thick. Molecules with a reactive head group attach to a solid surface and then pack into an ordered layer on their own, with the head group anchored and the tail pointing outward. Such films set wettability, block corrosion, and serve as interface layers in electronics and sensors.

How much did next-generation DNA sequencing cut the cost of a genome

Sequencing one human genome in 2000 took more than ten years and cost over one billion US dollars. Current instruments finish a genome in about a day for roughly one thousand dollars, and more than a million human genomes are now sequenced every year. The gain in speed and cost is on the order of a millionfold.

Why does long-range electron transfer in proteins matter

Every respiratory complex, photosynthetic reaction center, and metal-containing enzyme depends on moving electrons across distances far too long for direct contact between donor and acceptor. Understanding the rules lets chemists design drugs around a protein’s own electron-transfer routes, and it guides the design of artificial systems for converting light into stored energy.

How accurate are Nobel Prize in Chemistry predictions

They are better at naming the field than the person. A citation-based watchlist has named close to 500 researchers since 2002, and about 89 have gone on to win, roughly one in six. In some years a listed name wins within weeks, while in others the academy picks a field the list barely touched, so a preview maps momentum rather than outcome.

Could the 2026 chemistry prize go to gene editing instead of medicine

It could, because base editing and prime editing are chemistry-led inventions that happen to treat disease. The prize in physiology or medicine tends to reward a disease mechanism, while chemistry rewards a method. The 2020 CRISPR prize went to chemistry for that reason, which makes a chemistry prize for its successors plausible rather than strange.